# Effect of Ergocalciferol on Iron Metabolism in Individuals With Chronic Kidney Disease

> **NCT03073369** · PHASE4 · WITHDRAWN · sponsor: **University of Alabama at Birmingham**

## Conditions studied

- CKD
- Chronic Kidney Diseases
- Hepcidin
- Ergocalciferol
- Vitamin D
- Iron-deficiency
- Anemia

## Interventions

- **DRUG:** Ergocalciferol 50000 UNT
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03073369
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-01-01
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study didn't materialize for various reasons.
- **Last updated:** 2018-03-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03073369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03073369, "Effect of Ergocalciferol on Iron Metabolism in Individuals With Chronic Kidney Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03073369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*